Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)-Reference-Cited by-同舟云学术

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

Published:2015-09-04 Issue:12 Volume:17 Page:1133-1141
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Vora J.¹,Cohen N.²,Evans M.³,Hockey A.⁴,Speight J.⁵⁶⁷,Whately-Smith C.⁸

Affiliation:

1. Royal Liverpool University Hospital; Liverpool UK

2. Baker IDI Heart & Diabetes Institute; Melbourne Australia

3. University Hospital; Llandough UK

4. Sanofi; Guildford UK

5. AHP Research; Hornchurch UK

6. The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria; Melbourne Australia

7. School of Psychology, Deakin University; Burwood Australia

8. Whately-Smith Ltd; King's Langley UK

Funder

Sanofi

Novo Nordisk

Mount Sylvia Diatomite

Medtronic

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12528/fullpdf

Reference31 articles.

1. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;J Am Med Assoc,1999

2. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003

4. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

5. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison;Ilag;Clin Ther,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update;Endocrine Practice;2023-05

3. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

4. Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus;Evidence-Based Complementary and Alternative Medicine;2022-07-08

5. Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus;Diabetes Therapy;2022-06-30